Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| GBRG3 | Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) (GABAAR subunit gamma-3) | FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins | 4 | Alzheimer diseaseAnxiety disorderCorneal disease | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||
| GHR | P10912 | Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)] | Disease related genesFDA approved drug targetsHuman disease related genes | 1 | COVID-19MalariaMiddle East Respiratory Syndrome | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| GLP2R | O95838 | Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Bowel habit changeDigestive system diseaseIndeterminate colitis | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.50 | ||
| GLRA2 | P23416 | Glycine receptor subunit alpha-2 | Disease related genesFDA approved drug targetsPredicted membrane proteins | 4 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| GLT11 | Q8NCW6 | Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11) | Disease related genesEnzymesMetabolic proteins | 1 | Metabolism mediation | 1 | 0.50 | |||
| GNAQ | P50148 | Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q) | Cancer-related genesDisease related genesHuman disease related genes | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||||
| GP143 | P51810 | G-protein coupled receptor 143 (Ocular albinism type 1 protein) | Disease related genesG-protein coupled receptorsHuman disease related genes | 7 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| GPIX | P14770 | Platelet glycoprotein IX (GP-IX) (GPIX) (Glycoprotein 9) (CD antigen CD42a) | CD markersDisease related genesHuman disease related genes | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| GPVI | Q9HCN6 | Platelet glycoprotein VI (GPVI) (Glycoprotein 6) | Disease related genesHuman disease related genesPlasma proteins | 1 | Arterial occlusive diseaseCerebral ischaemic stroke | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| GRIK1 | P39086 | Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5) | FDA approved drug targetsPredicted membrane proteins | 3 | Dissociative neurological symptom disorderEpilepsy/seizureGeneral pain disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||
| HFE | Q30201 | Hereditary hemochromatosis protein (HLA-H) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| HTRA1 | Q92743 | Serine protease HTRA1 (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11) | Disease related genesEnzymesHuman disease related genes | Other mediation | 1 | 0.50 | ||||
| HYCCI | Q9BYI3 | Hyccin (Down-regulated by CTNNB1 protein A) | Disease related genesHuman disease related genesPredicted intracellular proteins | Metabolism mediation | 1 | 0.50 | ||||
| IGF1R | P08069 | Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] | Cancer-related genesCD markersDisease related genes | 1 | Adrenal cancerBreast cancerChronic kidney disease | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| IL21R | Q9HBE5 | Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360) | Cancer-related genesCD markersDisease related genes | 1 | Crohn diseasePostoperative inflammationSolid tumour/cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| IL31R | Q8NI17 | Interleukin-31 receptor subunit alpha (IL-31 receptor subunit alpha) (IL-31R subunit alpha) (IL-31R-alpha) (IL-31RA) (Cytokine receptor-like 3) (GLM-R) (hGLM-R) (Gp130-like monocyte receptor) (Gp130-like receptor) (ZcytoR17) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| IL6RB | P40189 | Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| INGR1 | P15260 | Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119) | CD markersDisease related genesFDA approved drug targets | 1 | Clinical-translation mediationImmune mediation | 1 | 0.50 | |||
| ITA3 | P26006 | Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain] | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ITA7 | Q13683 | Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form] | Disease related genesHuman disease related genesPotential drug targets | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ITB2 | P05107 | Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18) | CD markersDisease related genesHuman disease related genes | 1 | Cerebral ischaemiaInnate/adaptive immunodeficiencyIschaemic/haemorrhagic stroke | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| ITB5 | P18084 | Integrin beta-5 | Cancer-related genesPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ITB8 | P26012 | Integrin beta-8 | Cancer-related genesPredicted membrane proteins | 1 | Chronic kidney disease | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 1 | 0.50 | ||
| IYD1 | Q6PHW0 | Iodotyrosine deiodinase 1 (IYD-1) (EC 1.21.1.1) (Iodotyrosine dehalogenase 1) | Disease related genesEnzymesHuman disease related genes | 1 | Metabolism mediation | 1 | 0.50 | |||
| JAG1 | P78504 | Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339) | CD markersDisease related genesHuman disease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 |